Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
Veronica Veschi(Sapienza University of Rome), Giorgio Stassi(University of Palermo), Dario Giuffrida, Vincenzo Davide Pantina(University of Palermo), Lorenzo Memeo, Alice Turdo(Department of Health), Simone Di Franco(University of Palermo), Chiara Modica(Candiolo Cancer Institute), Melania Lo Iacono(University of Palermo), Miriam Gaggianesi(University of Palermo), Elena Tirrò(Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele), Elisabetta Sciacca(Queen Mary University of London), Cristina Colarossi(Istituto di Studi sul Mediterraneo (CNR - ISMed)), Paolo Vigneri(Humanitas University), Paola Bianca(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Matilde Todaro(University of Chieti-Pescara), Giuseppe Pistone(University of Palermo), Antonino Belfiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Veronica Vella(University of Milano-Bicocca), Maria Rita Bongiorno(University of Palermo), Gaetana Porcelli(Institute for Biomedical Research and Innovation), Laura Rosa Mangiapane(University of Palermo), Lorenzo Colarossi, Sebastiano Di Bella(University of Palermo), Francesco Verona(University of Palermo), Aroldo Rizzo(Ospedale Vincenzo Cervello), Irene Pillitteri(University of Palermo)
Cited by 36
Related Papers
CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
|Cell stem cell|2014|725
Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved
|Journal of Biological Chemistry|2002|491
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
|Nature Medicine|2022|277
Bone Morphogenetic Protein 4 Induces Differentiation of Colorectal Cancer Stem Cells and Increases Their Response to Chemotherapy in Mice
|Gastroenterology|2010|219
Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*
|British Journal of Dermatology|2020|175